CStone Announces Inclusion of Cejemly® (sugemalimab) as a First-Line Combination Therapy for NSCLC in ESMO Guideline

CStone Announces Inclusion of Cejemly® (sugemalimab) as a First-Line Combination Therapy for NSCLC in ESMO Guideline

SUZHOU, China, Feb. 10, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, today announced that its key product,...

CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4

CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4

SHANGHAI, Feb. 10, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the first...

Axcelis Announces Participation in SEMICON Korea 2025

Axcelis Announces Participation in SEMICON Korea 2025

Learn About the Latest Products and Upgrades that Accelerate Intelligent Solutions in Ion Implant BEVERLY, Mass., Feb. 10, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for...

Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis

Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis

CHENGDU, China, Feb. 8, 2025 /PRNewswire/ -- KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of Stapokibart...

ZK International Postpones Shareholder Call

ZK International Postpones Shareholder Call

WENZHOU, China, Feb. 8, 2025 /PRNewswire/ -- ZK International Group Co., Ltd. (Nasdaq: ZKIN) (" ZK International" or the "Company"), a leading engineering Company focused on high-performance steel products, announces that its previously scheduled...

SunCar Technology Group Announces Share Repurchase Program

SunCar Technology Group Announces Share Repurchase Program

NEW YORK, Feb. 7, 2025 /PRNewswire/ -- SunCar Technology Group Inc. ("SunCar" or the "Company") (Nasdaq: SDA), an innovative leader in cloud-based B2B auto services and auto e-insurance in China, today announced that its board of directors has...

Grey/Ven Appoints Ilana Kugel as Creative Director for Womenswear

Grey/Ven Appoints Ilana Kugel as Creative Director for Womenswear

Announces NYFW Runway Show and Launch of Luxury Handbag and Accessories NEW YORK, Feb. 7, 2025 /PRNewswire/ -- Grey/Ven, the renowned purveyor of quiet luxury, proudly announces the appointment of CFDA-recognized designer Ilana Kugel as the Creative...

CLPS Incorporation Announces the Launch of Nibot RPA Product, Expanding Automation Services into the Global Market

CLPS Incorporation Announces the Launch of Nibot RPA Product, Expanding Automation Services into the Global Market

HONG KONG, Feb. 7, 2025 /PRNewswire/ -- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS), today announced the launch of Nibot, a new generation of Robotic Process Automation (RPA) product developed by its wholly owned subsidiary, CLPS...

Acer Announces January Revenues at NT$15.07 Billion

Acer Announces January Revenues at NT$15.07 Billion

TAIPEI, Feb. 7, 2025 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its consolidated revenues for January at NT$15.07 billion, down 1.0%, which was flattish year-on-year (YoY). Chromebooks revenue increased by 56.5% YoY in January, showing...

Nuance Pharma Announces Approval of Ohtuvayre™ (ensifentrine) in Macau SAR, China

Nuance Pharma Announces Approval of Ohtuvayre™ (ensifentrine) in Macau SAR, China

Ohtuvayre™is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients First inhaled COPD treatment providing bronchodilation and non-steroidal anti-inflammatory effects SHANGHAI, Feb. 7, 2025...

  • 1
  • ...
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • ...
  • 86
  • menu
    menu